Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: A case report

被引:22
作者
Bissonnette, Lyne [1 ]
April, Pierre-Marc [1 ]
Dumais, Rejean [2 ]
Boire, Gilles [1 ]
Roux, Sophie [1 ]
机构
[1] Univ Sherbrooke, Fac Med, Div Rheumatol, Sherbrooke, PQ, Canada
[2] Univ Sherbrooke, Div Orthopaed Surg, Sherbrooke, PQ J1K 2R1, Canada
关键词
Atypical fracture; Tibial diaphyseal fracture; Bisphosphonates; SUPPRESSED BONE TURNOVER; FEMORAL FRACTURES; ALENDRONATE THERAPY; RISK;
D O I
10.1016/j.bone.2013.07.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atypical subtrochanteric femoral shaft fractures (AFFs) have recently emerged as a potential long-term complication of bisphosphonate therapy. In 2010, the American Society for Bone and Mineral Research (ASBMR) Task Force published a definition for AFF consisting of 5 major and 7 minor features. Little attention has so far been paid to the possibility that bisphosphonate-associated atypical fractures may also involve the diaphysis of other long bones. We report here the case of a patient on long-term bisphosphonate therapy who presented a diaphyseal tibial insufficiency fracture fulfilling all the major criteria (except for the location), and a number of the minor criteria of an atypical fracture. Our case report suggests the need for greater awareness of the possibility of atypical fractures at other sites, particularly in weight-bearing long bones other than the femur, and suggests that long-term bisphosphonate therapy may also contribute to the occurrence of these atypical fractures. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:406 / 409
页数:4
相关论文
共 28 条
[1]  
Allen MR., 2007, IBMS BoneKEy, V4, P49, DOI [DOI 10.1138/20060248, 10.1138/20060248]
[2]   Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis [J].
Armamento-Villareal, Reina ;
Napoli, Nicola ;
Panwar, Vinita ;
Novack, Deborah .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19) :2048-2050
[3]   Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur [J].
Black, Dennis M. ;
Kelly, Michael P. ;
Genant, Harry K. ;
Palermo, Lisa ;
Eastell, Richard ;
Bucci-Rechtweg, Christina ;
Cauley, Jane ;
Leung, Ping Chung ;
Boonen, Steven ;
Santora, Arthur ;
de Papp, Anne ;
Bauer, Douglas C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (19) :1761-1771
[4]   Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women [J].
Boivin, GY ;
Chavassieux, PM ;
Santora, AC ;
Yates, J ;
Meunier, PJ .
BONE, 2000, 27 (05) :687-694
[5]   Atypical Insufficiency Fracture of the Tibia Associated With Long-Term Bisphosphonate Therapy [J].
Breglia, Michael D. ;
Carter, John D. .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (02) :76-78
[6]   Bilateral Low-Energy Simultaneous or Sequential Femoral Fractures in Patients on Long-Term Alendronate Therapy [J].
Capeci, Craig M. ;
Tejwani, Nirmal C. .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (11) :2556-2561
[8]   Prophylactic Intramedullary Fixation for Bisphosphonate-related Subtrochanteric Stress Fracture [J].
Fowler, John R. ;
Criner, Katharine ;
Craig, Matthew R. .
ORTHOPEDICS, 2012, 35 (06) :E954-E957
[9]   Subtrochanteric insufficiency fractures in patients on alendronate therapy - A caution [J].
Goh, S.-K. ;
Yang, K. Y. ;
Koh, J. S. B. ;
Wong, M. K. ;
Chua, S. Y. ;
Chua, D. T. C. ;
Howe, T. S. .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2007, 89B (03) :349-353
[10]   A biomechanical enigma:: Why are tibial fractures not more frequent in the elderly? [J].
Grütter, R ;
Cordey, J ;
Wahl, D ;
Koller, B ;
Regazzoni, P .
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2000, 31 :72-77